Cargando…

Loss of PTEN-Induced Kinase 1 Regulates Oncogenic Ras-Driven Tumor Growth By Inhibiting Mitochondrial Fission

Mitochondrial metabolism and dynamics (fission and fusion) critically regulate cell survival and proliferation, and abnormalities in these pathways are implicated in both neurodegenerative disorders and cancer. Mitochondrial fission is necessary for the growth of mutant Ras-dependent tumors. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Dantong, Han, Fengtong, Sun, Liuke, Agnihotri, Sandeep K., Hu, Ying, Büeler, Hansruedi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117651/ https://www.ncbi.nlm.nih.gov/pubmed/35600352 http://dx.doi.org/10.3389/fonc.2022.893396

Ejemplares similares

Lack of PINK1 alters glia innate immune responses and enhances inflammation-induced, nitric oxide-mediated neuron death
por: Sun, Liuke, et al.
Publicado: (2018)

Mitochondrial and Autophagic Regulation of Adult Neurogenesis in the Healthy and Diseased Brain
por: Büeler, Hansruedi
Publicado: (2021)

RAS: Striking at the Core of the Oncogenic Circuitry
por: Gimple, Ryan C., et al.
Publicado: (2019)

Editorial: Oncogenic RAS-Dependent Reprogramming of Cellular Plasticity
por: Konstantinidou, Georgia, et al.
Publicado: (2020)

The Importance of microRNAs in RAS Oncogenic Activation in Human Cancer
por: Roncarati, Roberta, et al.
Publicado: (2019)

Hair follicle regeneration suppresses Ras-driven oncogenic growth
por: Pineda, Cristiana M., et al.
Publicado: (2019)

Ferroptosis: A Specific Vulnerability of RAS-Driven Cancers?
por: Andreani, Cristina, et al.
Publicado: (2022)

Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation
por: Bettoun, Audrey, et al.
Publicado: (2016)

Correction: Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation
por: Bettoun, Audrey, et al.
Publicado: (2018)

New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhesion Kinase Pathway
por: Alfieri, Roberta, et al.
Publicado: (2017)

The Synergistic Effect of Conditional Pten Loss and Oncogenic K-ras Mutation on Endometrial Cancer Development Occurs via Decreased Progesterone Receptor Action
por: Kim, Tae Hoon, et al.
Publicado: (2010)

PTEN loss promotes Warburg effect and prostate cancer cell growth by inducing FBP1 degradation
por: Song, Changze, et al.
Publicado: (2022)

Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity
por: Sánchez-Alvarez, Rosa, et al.
Publicado: (2020)

Repression of CD24 surface protein expression by oncogenic Ras is relieved by inhibition of Raf but not MEK or PI3K
por: Pallegar, Nikitha K., et al.
Publicado: (2015)

Oncogenic RAS Mutants Confer Resistance of RMS13 Rhabdomyosarcoma Cells to Oxidative Stress-Induced Ferroptotic Cell Death
por: Schott, Christina, et al.
Publicado: (2015)

Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines
por: Klein, Christoph, et al.
Publicado: (2000)

Genomic Deletion at 10q23 in Prostate Cancer: More Than PTEN Loss?
por: Poluri, Raghavendra Tejo Karthik, et al.
Publicado: (2018)

Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth
por: Shin, Seung-Min, et al.
Publicado: (2020)

BTB-Zinc Finger Oncogenes Are Required for Ras and Notch-Driven Tumorigenesis in Drosophila
por: Doggett, Karen, et al.
Publicado: (2015)

Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
por: Catalano, Antonella, et al.
Publicado: (2021)

Bioinformatics-Driven Identification of p62 as A Crucial Oncogene in Liver Cancer
por: Wang, Ling, et al.
Publicado: (2022)

The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
por: Sabapathy, Kanaga
Publicado: (2015)

A Case Report of Metastatic Castration-Resistant Prostate Cancer Harboring a PTEN Loss
por: Myint, Zin W., et al.
Publicado: (2021)

Mitochondrial Ca(2+) Remodeling is a Prime Factor in Oncogenic Behavior
por: Rimessi, Alessandro, et al.
Publicado: (2015)

The Role of Wild-Type RAS in Oncogenic RAS Transformation
por: Sheffels, Erin, et al.
Publicado: (2021)

Corrigendum: The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
por: Sabapathy, Kanaga
Publicado: (2021)

Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis
por: Caraffini, Veronica, et al.
Publicado: (2020)

Focus on PTEN Regulation
por: Bermúdez Brito, Miriam, et al.
Publicado: (2015)

Preventing Mitochondrial Fission Impairs Mitochondrial Function and Leads to Loss of Mitochondrial DNA
por: Parone, Philippe A., et al.
Publicado: (2008)

Systemic Deficiency of PTEN Accelerates Breast Cancer Growth and Metastasis
por: Chen, Jing, et al.
Publicado: (2022)

Salt-Inducible Kinase 2: An Oncogenic Signal Transmitter and Potential Target for Cancer Therapy
por: Chen, Fangyu, et al.
Publicado: (2019)

Hyperphosphorylated PTEN exerts oncogenic properties
por: van Ree, Janine H., et al.
Publicado: (2023)

TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN-loss
por: Pietrzak, Karolina, et al.
Publicado: (2020)

Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase C
Publicado: (1991)

Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
por: Heidorn, Sonja J., et al.
Publicado: (2010)

Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3
por: Ahn, Sung Yong, et al.
Publicado: (2017)

Increased Mitochondrial Calcium Sensitivity and Abnormal Expression of Innate Immunity Genes Precede Dopaminergic Defects in Pink1-Deficient Mice
por: Akundi, Ravi S., et al.
Publicado: (2011)

Transforming ras oncogenes and multistage carcinogenesis.
por: Balmain, A.
Publicado: (1985)

Ras oncogene mutation in multiple myeloma
Publicado: (1989)

Genomic Rearrangements of PTEN in Prostate Cancer
por: Phin, Sopheap, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_abv9cuq0ojj613i8nctkne0o6i